Kieger Sustainable Healthcare Fund Class B EUR Accumulating

Reference Data

ISIN LU2488092649
Valor Number 119403766
Bloomberg Global ID
Fund Name Kieger Sustainable Healthcare Fund Class B EUR Accumulating
Fund Provider Kieger AG Kieger AG
Limmatstrasse 264, CH-8005 Zürich
Phone: +41 44 444 18 44
Web: https://kieger.com/
E-Mail: info@kieger.com
Fund Provider Kieger AG
Representative in Switzerland ACOLIN Fund Services AG
Zürich
Phone: +41 44 396 96 96
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). No guarantee can be given that the investment objective will be achieved.
Peculiarities

Fund Prices

Current Price * 110.14 EUR 31.03.2025
Previous Price * 110.08 EUR 28.03.2025
52 Week High * 119.70 EUR 30.08.2024
52 Week Low * 108.71 EUR 13.03.2025
NAV * 110.14 EUR 31.03.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 270,684,394
Unit/Share Assets *** 112,846
Trading Information SIX

Performance

YTD Performance -0.62% 31.12.2024
31.03.2025
YTD Performance (in CHF) +1.15% 31.12.2024
31.03.2025
1 month -7.18% 28.02.2025
31.03.2025
3 months -0.62% 31.12.2024
31.03.2025
6 months -4.11% 30.09.2024
31.03.2025
1 year -1.18% 02.04.2024
31.03.2025
2 years +10.14% 06.07.2023
31.03.2025
3 years - -
5 years - -

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 5.89%
UnitedHealth Group Inc 5.37%
Abbott Laboratories 5.02%
Novartis AG Registered Shares 4.71%
AstraZeneca PLC 4.63%
Intuitive Surgical Inc 4.56%
Thermo Fisher Scientific Inc 4.50%
Roche Holding AG 4.26%
Novo Nordisk AS Class B 3.90%
Boston Scientific Corp 3.73%
Last data update 31.12.2024

Cost / Risk

TER *** 0.99%
TER date *** 30.09.2023
Performance Fee ***
PTR
Max. Management Fee *** 0.85%
Ongoing Charges *** 0.99%
SRRI ***
SRRI date *** 28.02.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)